Source:http://linkedlifedata.com/resource/pubmed/id/19048226
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2009-2-4
|
| pubmed:abstractText |
The aim of this study was to investigate the impact of using a non-diabetes-specific cardiovascular disease (CVD) risk calculator to determine eligibility for statin therapy according to current UK National Institute for Health and Clinical Excellence (NICE) guidelines for those patients with type 2 diabetes who are at an increased risk of CVD (10 year risk >or=20%).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
1432-0428
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
52
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
394-7
|
| pubmed:meshHeading |
pubmed-meshheading:19048226-Cardiovascular Diseases,
pubmed-meshheading:19048226-Cholesterol, LDL,
pubmed-meshheading:19048226-Diabetes Mellitus, Type 2,
pubmed-meshheading:19048226-Diabetic Angiopathies,
pubmed-meshheading:19048226-Humans,
pubmed-meshheading:19048226-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19048226-Patient Selection,
pubmed-meshheading:19048226-Risk Assessment
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.
|
| pubmed:affiliation |
Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, UK. Hermione.Price@dtu.ox.ac.uk
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|